Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Hellerup
SEC filing record 1 source field available
Fiscal year end
31 December
Ascendis Pharma A/S has filed 768 SEC EDGAR filings since 01 Aug 2014

SEC filing history

Showing 376-400 of 768 matching filings.

Per page
25
Current page
16
6-K File 001-36815

6-K

Filing date
29 Mar 2022
Reporting date
29 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
14 Mar 2022
Reporting date
14 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
14 Mar 2022
Reporting date
14 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
09 Mar 2022
Reporting date
09 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
02 Mar 2022
Reporting date
02 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88586

SCHEDULE 13G/A

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88586

ASCENDIS PHARMA A/S

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88586

SC 13G/A filing

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88586

JANUS HENDERSON GROUP PLC OWNS >5%

Filing date
10 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
09 Feb 2022
Reporting date
09 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88586

SC 13G/A filing

Filing date
09 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88586

SEC SCHEDULE 13G

Filing date
04 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88586

ASCENDIS PHARMA A/S

Filing date
04 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
13 Jan 2022
Reporting date
13 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
12 Jan 2022
Reporting date
12 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
10 Jan 2022
Reporting date
10 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
10 Jan 2022
Reporting date
10 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
04 Jan 2022
Reporting date
04 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
16 Dec 2021
Reporting date
15 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
15 Dec 2021
Reporting date
14 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
13 Dec 2021
Reporting date
13 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-261550

S-8

Filing date
09 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
18 Nov 2021
Reporting date
18 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
18 Nov 2021
Reporting date
18 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .